1. Annexin A2 promotion of hepatocellular carcinoma tumorigenesis via the immune microenvironment
   Li-Wei Qiu et al, 2020, WJG CrossRef
2. Annexin A5 as a marker for hepatocellular carcinoma in cirrhotic hepatitis C virus patients
   Waleed Mohamed Serag et al, 2021, Egypt Liver Journal CrossRef
3. Evaluation of Annexins Family as Potential Biomarker for Predicting Progression and Prognosis in Clear Renal Cell Carcinoma
   Jiyu Zhao et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef
4. Mechanism of a Herbal Formula Associated with Prognosis and Immune Infiltration in LIHC: Transcriptomics Analysis and Molecular Dynamics Simulations
   Jiankun Xu et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef
5. Possible Role of Extracellular Vesicles in Hepatotoxicity of Acetaminophen
   Martina Šrajer Gajdošik et al, 2022, IJMS CrossRef
6. RNA splicing: a dual-edged sword for hepatocellular carcinoma
   Anjali Kashyap et al, 2022, Med Oncol CrossRef
7. TGF-1 mRNA, AFP-L3, and Annexin II in the Early and Late Detection of Hepatocellular Carcinoma: The Diagnostic Value
   Eman Youssef et al, 2022, Open Access Maced J Med Sci CrossRef
8. Annexin A protein family: Focusing on the occurrence, progression and treatment of cancer
   Huhu Zhang et al, 2023, Front. Cell Dev. Biol. CrossRef
9. Development of an Inflamed High Throughput Stem-cell-based Gut Epithelium Model to Assess the Impact of Annexin A1
   Milena Fronza Broering et al, 2024, Stem Cell Rev and Rep CrossRef